TITLE

Uricosuric Drugs in Gout

AUTHOR(S)
Jennings, G. H.
PUB. DATE
February 1965
SOURCE
British Medical Journal;2/13/1965, Vol. 1 Issue 5432, p449
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64057582

 

Related Articles

  • Anti-gout Drugs. Seifert, Roland // Encyclopedic Reference of Molecular Pharmacology;2004, p76 

    The article presents an encyclopedia entry for the term "anti-gout drugs," which are used or the treatment and management of gout or hyperuricemia. It provides information on the pathophysiology and clinical manifestations of gout. It discusses the structures of anti-gout drugs and their...

  • uricosuric agent.  // Taber's Cyclopedic Medical Dictionary;2005, p2271 

    A definition of the term "uricosuric agent" is presented. It refers to a drug that increases the urinary excretion of uric acid, thereby reducing the concentration of uric acid in the blood. It is used to treat gout.

  • Gout. Rott, Keith T.; Agudelo, Carlos A. // JAMA: Journal of the American Medical Association;6/4/2003, Vol. 289 Issue 21, p2857 

    Discusses the diagnosis and treatment of gout. Presentation of the condition as acute inflammatory monarthritis; Misdiagnosis as cellulitis or septic arthritis; Discussion of hyperuricemia, which can be caused by overproduction or overexcretion of uric acid; Risk factors for hyperuricemia and...

  • On the link between diet and gout.  // Tufts University Diet & Nutrition Letter;Nov92, Vol. 10 Issue 9, p7 

    Examines the malady known as gout, and recommends ways of controlling this severe form of arthritis. Foods high in compounds known as purines, which break down into a substance called uric acid; High levels of uric acid and gout; Drugs that reduce uric acid buildup, such as allopurinol;...

  • RASBURICASE NO TRATAMENTO DE GOTA TOFÁCEA. Ribeiro, Ana; Bogas, Mónica; Costa, José; LúciaCosta; Araújo, Domingos // Acta Reumatológica Portuguesa;jul-set2009, Vol. 34 Issue 3, p551 

    The main obstacle to the treatment of hyperuricemia in patients with allergy to allopurinol is the limited availability of equally efficient alternative drugs. The authors present a clinical case of a patient with incapacitant tophaceus gout, allergy to allopurinol and contraindication for...

  • MUSCULOSKELETAL DISORDERS.  // MPR - Pharmacist's Edition;Summer2012, Vol. 6 Issue 2, p200 

    The article offers information on the literature of several drugs for musculoskeletal disorders. It notes Novartis AG's Voltaren-XR, a nonsteroidal anti-inflammatory drug (NSAID), which is indicated for the management of osteoarthritis and rheumatoid arthritis. It mentions Probenecid, a...

  • Febuxostat: A Novel Agent for Management of Hyperuricemia in Gout. Bisht, Manisha; Bist, S. S. // Indian Journal of Pharmaceutical Sciences;Nov/Dec2011, Vol. 73 Issue 6, p597 

    Gout is a metabolic disorder characterized by elevated uric acid levels in the body, associated with painful arthritis, tophi and nephropathy. The most frequently used pharmacologic urate lowering strategies involve reducing urate production with a xanthine oxidase inhibitor and enhancing...

  • Uricosuric Drug.  // Encyclopedic Reference of Molecular Pharmacology;2004, p952 

    A definition of the term "uricosuric drugs" is presented. It refers to a drug that increases renal excretion of uric acid by allowing its renal reabsorption. Benz-bromarone, probenecid and sulfinpyrazone are therapeutically used uricosuric drugs.

  • Management of Acute and Chronic Gouty Arthritis: Present State-of-the-Art. Schlesinger, Naomi // Drugs;2004, Vol. 64 Issue 21, p2399 

    There are three stages in the management of gout: (i) treating the acute attack; (ii) lowering excess stores of uric acid to prevent flares of gouty arthritis and to prevent tissue deposition of urate; and (iii) providing prophylaxis to prevent acute flares. It is important to distinguish...

  • How effective is prophylactic therapy for gout in people with prior attacks? WinklerPrins, Vincent J.; Weismantel, Arlene M. // Journal of Family Practice;Oct2004, Vol. 53 Issue 10, p837 

    The majority of gout sufferers are uric acid undersecretors rather than overproducers. However, many patients will have a combination of these 2 processes, as well as caloric or purine overindulgence. This article seeks to determine the efficacy of adding daily colchicine to uricosurics in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics